$IMAX

Exhibitor stocks rose 70% this year, with MoffettNathanson predicting $10.5B in box-office receipts, down 8% from 2019. Analysts raised target prices for Imax to $64 and Cinemark to $41. Legendary made a new offer for Lionsgate, while Publicis Group's acquisition of LiveRamp was approved with conditions. 32 Equity and General Atlantic plan a sports investment fund.

AMC Entertainment (AMC) shares are up 83% YTD to $2.86, while Cinemark (CNK) is up 68% YTD to $38.72, and IMAX (IMAX) is up 38% YTD to $51.11. AMC recently refinanced debt, pushing maturities into the next decade, and expects strong theatrical performance. AMC's debt load remains a concern, with negative stockholders' equity. Cinemark offers a less leveraged theater investment. The SPDR S&P 500 ETF (SPY) is up 12% YTD.

Analysts expect Procter & Gamble (PG) to show stronger sales, while UBS lowers Six Flags (SIX) price target due to accident concerns. UBS warns Apple (AAPL) iPhone demand may weaken. Bank of America upgrades Fox (FOXA) and Meta (META), citing growth prospects. Roblox (RBLX) sees modest player activity recovery. Semtech targets data center revenue growth. Chipotle (CMG) may report in-line sales. Spectrum Brands (SPB) gets Buy rating. Microsoft (MSFT) price target raised.

Wells Fargo raised its price target on Imax (NYSE:IMAX) to $55, citing record global box office performance. The firm increased its Q3 adjusted EBITDA estimate to $100M and global box office estimate to $712M. Other analysts also raised targets, with StoneX at $65 and Rosenblatt at $65. Imax shares are up 63% over the past year, trading at $51.69.

Wedbush raised its price target for IMAX Corp. to $60, citing record Q3 box office performance and strong financial projections. The firm expects $712M in global IMAX box office revenue, surpassing 2026 guidance. Wedbush forecasts Q3 revenue of $161M, EBITDA of $84M, and EPS of $0.98, all above consensus. Growth drivers include more IMAX titles, global expansion, and alternative content. IMAX is set to report Q3 results the week of October 26.

Rosenblatt maintained a Buy rating and $65 price target on Imax, implying a 25.8% upside. The firm cited strong box office performance, with Q3 Gross Box Office at $712 million, up 94% YoY, driven by 'The Odyssey'. Analysts expect continued growth from upcoming film releases.

AMC Entertainment (AMC) stock rose 5% to $3.16, a week after closing a $3.97B refinancing deal. Cinemark (CNK) gained 4%, while IMAX (IMAX) fell 0.6%. AMC's refinancing extends debt maturities into the next decade, reducing annual interest expenses. AMC's Q2 2026 revenue grew 14.2% to $1.6B, with adjusted EBITDA up 70% to $321.4M. The company plans to add 150-250 premium screens in 2-4 years.

Wedbush analysts believe IMAX's market position is secure despite reports of a potential Disney-led coalition. They cite IMAX's strong brand, existing studio partnerships, and regulatory hurdles as protective factors. Disney's approach to Skydance/Paramount and Universal for a premium screen network is seen as unlikely to threaten IMAX in the near term, according to Wedbush.

B. Riley Securities increased its estimates for IMAX, citing strong box office performance of The Odyssey, which earned $534M globally. Analyst Drew Crum noted the film's outperformance in September.

StoneX kept a Buy rating on Imax with a $65 price target, suggesting a 28.5% upside from its Oct 6 close. The firm cited Imax's strong 2027 content pipeline and record 3Q26 box office performance of $712 million as key drivers. According to StoneX, these factors support earnings growth and high margins.